CD28 and neoplasm: In colorectal cancer, tumor cell-derived extracellular vesicles containing miR-424 inhibited the CD28-CD80/86 costimulatory pathway in tumor-infiltrating T cells and dendritic cells, a phenomenon that resulted an increase in the tumor’s response to immune checkpoint blockade therapies (Zhao et al., 2021).